Medicare Enrolled

Dr. Kyriakos Papadopoulos, M.D.

Hematology & Oncology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4383 MEDICAL DR, San Antonio, TX 78229
2105935700
In practice since 2005 (20 years)
NPI: 1376546861 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Papadopoulos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Papadopoulos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Papadopoulos

Dr. Kyriakos Papadopoulos is a hematology & oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Papadopoulos performed 2,376 Medicare services across 672 unique beneficiaries.

Between the years covered by Open Payments, Dr. Papadopoulos received a total of $1,047 from 16 pharmaceutical and/or device companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Papadopoulos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 42% volume in TX $1,047 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,376
Medicare services
Top 42% in TX for hematology & oncology
672
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~119 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Anti-nausea injection (Aloxi/palonosetron) 510 $1 $24
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
278 $96 $373
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
273 $10 $32
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
273 $8 $23
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
198 $96 $377
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
125 $48 $205
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
113 $69 $263
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
88 $42 $165
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
73 $12 $58
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
65 $11 $47
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
61 $22 $86
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
52 $1 $3
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
33 $4 $13
Coagulation assessment blood test
A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood.
29 $6 $18
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
26 $46 $184
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
25 $6 $19
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
24 $10 $42
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
21 $140 $523
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
18 $29 $131
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
17 $6 $18
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
17 $25 $137
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
16 $7 $20
Direct bilirubin level test
A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver.
15 $5 $15
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
14 $15 $59
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
12 $1 $9
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.1% high complexity
30.2% medium
50.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,047
Total received (2018-2024)
Avg $174/year across 6 years
Bottom 31% in TX for hematology & oncology
16
Companies
32
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,047 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$78
2023
$115
2022
$155
2021
$12
2019
$323
2018
$363

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bayer HealthCare Pharmaceuticals Inc.
$329
Regeneron Healthcare Solutions, Inc.
$131
Celgene Corporation
$120
PFIZER INC.
$118
Lilly USA, LLC
$56
Regeneron Pharmaceuticals, Inc.
$55
Merck Sharp & Dohme LLC
$39
Tempus AI, Inc
$35
E.R. Squibb & Sons, L.L.C.
$30
Merck Sharp & Dohme Corporation
$26
Takeda Pharmaceuticals U.S.A., Inc.
$23
Genentech USA, Inc.
$22
Novartis Pharmaceuticals Corporation
$20
EMD Serono, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Top 3 companies account for 55.4% of total payments
Associated products mentioned in payments ›
ALIMTA · Bavencio · CYRAMZA · GAZYVA · GILOTRIF · KEYTRUDA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · OPDIVO · OPDUALAG · PROMACTA · Pomalyst · REBLOZYL · SOMATULINE DEPOT · Stivarga · Vitrakvi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $44 per 100 Medicare services performed
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Papadopoulos is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Papadopoulos experienced with anti-nausea injection (aloxi/palonosetron)?
Based on Medicare claims data, Dr. Papadopoulos performed 510 anti-nausea injection (aloxi/palonosetron) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Papadopoulos receive payments from pharmaceutical companies?
Yes. Dr. Papadopoulos received a total of $1,047 from 16 companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Papadopoulos's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Papadopoulos's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Papadopoulos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →